Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2023-07-17
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objectives of this study are:
* To quantify the relationship between balance and aspects of neuromuscular function in individuals with COPD, and compared to age-matched healthy controls
* To understand the lived experience of people with COPD and their carers
Participants will attend an appointment at the University rehab lab to:
* Complete a balance test
* Fill out some questionnaires on mood, health status and balance and falls
* Complete some walking tests
* Have their body composition measured
* Have the function and strength of their leg nerves and muscles tested Researchers will compare people with COPD and healthy controls (older adults without COPD or other conditions known to impact balance) to see if any of the things measured are impacting the balance of people with COPD more than their peers without COPD.
* For 10 people with COPD only they will be visited at home to observe how they carry out everyday tasks and 5 of those 10 will have a follow up interview.
Researchers will take notes and record interviews and look for similarities and interesting points in the notes and transcripts of the interviews to build a picture of what living with COPD is like.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Relationship Between Pain, Balance and Gait in People With Chronic Obstructive Pulmonary Disease
NCT04202991
Activity, Balance and COPD (ABCOPD)
NCT04006015
Balance Training in Chronic Obstructive Pulmonary Disease
NCT05972239
Balance Training in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01424098
Postural Control in Chronic Obstructive Pulmonary Disease
NCT06863246
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COPD group
People with a spirometry confirmed diagnosis of Chronic Obstructive Pulmonary Disease (COPD)
No interventions assigned to this group
Healthy Controls
Older adults over the age of 55 who do not have COPD
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a spirometry confirmed diagnosis of COPD as per GOLD guidelines
* Stable COPD (six weeks clear of exacerbation)
* 55 years or over at the point of recruitment
* Able to communicate with good verbal English or use adaptive equipment to communicate
* Male or female Controls
* Free from a diagnosis of COPD (confirmed by spirometry)
* 55 years or over at the point of recruitment
* Able to communicate with good verbal English or use adaptive equipment to
* Communicate
* Male or female
Exclusion Criteria
* Recent exacerbation of COPD (within the last six weeks)
* Under 55 years of age at the point of recruitment
* Any neurological or musculoskeletal diagnoses (e.g., strokes, Parkinson's disease or chronic pain that interferes with ability to safely complete the tests
* Unable to provide written informed consent
* Unable to speak English or no translation options available
* Diagnosed but not corrected visual, vestibular disturbance and peripheral neuropathy
* Vasovagal syncope
* Not independent living (e.g., living in a care home or prison) Controls
* Abnormal lung function (FEV1 and FVC equal to or greater than 80% and FEV1/FVC equal to greater than 70%)
* Under 55 years of age at the point of recruitment
* Any neurological or musculoskeletal impairment that would significantly affect balance impacting ability to safely complete the assessments
* Unable to provide written informed consent
* Unable to speak English or no translation options available
* Any uncorrected visual or somatosensory disturbance
* Vasovagal syncope
* Living in a care home or in prison
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Teesside University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samantha Harrison
Professor of Respiratory Rehabilitation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samantha L Harrison, PhD
Role: STUDY_CHAIR
Teesside University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Teesside University
Middlesbrough, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIHR300856
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2022 Aug 10959 Harrison
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.